Cefazolin: Clinical Trials

6 trials of Cefazolin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 11Completed 1
Phase 31Completed 1

Follow Cefazolin: new trials by email Literature Review of Cefazolin trials Research Report on Cefazolin

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
Cefazolin, Dalbavancin, Daptomycin - Staphylococcal Bacteraemia
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2002021-04-222024-12-10
Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions
Cefazolin - Premalignant Vulvar Lesion, Benign Vulvar Lesion
Phase 2CompletedWashington University School of Medicine502018-07-132022-11-21
The Effect of Bowel Preparation on Perioperative Bleeding
PEG, placebo, Cefazolin - Surgery
Phase 1 / Phase 2CompletedIsfahan University of Medical Sciences1052014-07-012015-07-10
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
Vancomycin - Bacteremia
Phase 2CompletedDuke University5092011-02-012018-01-05
Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
IV cefazolin plus oral probenecid and placebo cephalexin, Oral cephalexin and saline IV plus probenecid placebo - Cellulitis
Phase 2CompletedKelowna General Hospital2062010-05-012018-08-13
Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax
Ancef or Clindamycin, Placebo - Hemopneumothorax, Pneumothorax
Phase 2 / Phase 3CompletedSt. Luke's Hospital, Pennsylvania502005-07-012010-05-21

Conditions studied

Bacteremia (2)  ·  Cellulitis (1)  ·  Emergencies (1)  ·  Hemopneumothorax (1)  ·  Pneumothorax (1)  ·  Staphylococcal Infections (1)

Sponsors

Duke University (1)  ·  Isfahan University of Medical Sciences (1)  ·  Kelowna General Hospital (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  St. Luke's Hospital, Pennsylvania (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  Canada (2)  ·  Iran (1)  ·  Spain (1)

Top investigators

Dawn Dalen, PharmD (1)  ·  Mary M Mullen, M.D. (1)  ·  Nathaniel McQuay, MD (1)  ·  Peter Zed, PharmD (1)  ·  Reza Abbasi, MD (1)  ·  Vance Fowler, MD (1)

Results publications

PMID 25532706, PMID 29914924, PMID 30264119, PMID 35578360, PMID 40802264, PMID 41999282

NIH funding

5UM1AI104681-12 (1)